All Posts By

Team@VPEG4

VPEG3 Quarterly Report December 2018

21 February 2019 VPEG3 Quarterly Report for the 3 months ending 31 December 2018 Special Points of Interest; VPEG3 commits $7.5m to Mercury Capital Fund 3, a $600m mid-market expansion fund, managed by Sydney, Australia based, Mercury Capital. Allegro Fund III acquires Endeavour Learning Group, Australia’s largest higher education provider of natural therapists Adamantem Capital Fund 1 completes the ‘public to private’ acquisition of…

Continue Reading

VPEG3 Commits $10 million to Next Capital Fund IV

23 December 2018 Vantage Private Equity Growth 3 today announced that it had completed a $10 million investment commitment to Next Capital Fund IV managed by Sydney, Australia headquartered, Next Capital Management Pty Ltd. Next Capital Management (www.nextcapital.com.au) was established in 2005 by Sandy Lockhart, Patrick Elliott and John White, who were former principals of Macquarie Bank’s private equity arm, Macquarie…

Continue Reading

VPEG3 Quarterly Report September 2018

26 November 2018 VPEG3 Quarterly Report for the 3 months ending 30 September 2018  Special Points of Interest; VPEG3 approves a co-investment with Advent Partners 1into Australia’s leading independent manufacturer of craft beer and premium alcoholic beverages, Tribe Brewing. Anchorage Capital Partners Fund IIIacquires Australia’s leading commercial laundry operator, South Pacific Laundry Advent Partners 2invests into Miso Holdco Pty Ltd, a leading provider of Information…

Continue Reading

Notice of VPEG3 2018 Annual General Meeting

31 October 2018 The 2018 Annual General Meeting (AGM) of Vantage Private Equity Growth 3 (VPEG3) consisting of Vantage Private Equity Growth 3, LP (ILP NO. L0000419E) (VPEG3, LP) and Vantage Private Equity Growth Trust 3A, (VPEG3A) will commence at 11:30am AEDST on Thursday 29 November 2018 at L17, 8 Chifley Square, Sydney Investors seeking to attend the AGM please advise Vantage…

Continue Reading

VPEG3 Quarterly Report June 2018

22 August 2018 VPEG3 Quarterly Investor Report for the 3 months ending 30 June 2018  Special Points of Interest; Odyssey Fund 8 completes the acquisition of Mine Site Technologies a leading provider of unified communication products Adamantem Capital Fund 1 invests in Servian, a specialised data and analytics consultancy firm VPEG3’s portfolio expands to eight underlying companies operating across a…

Continue Reading

VPEG3 Quarterly Report March 2018

22 May 2018 VPEG3 Quarterly Investor Report for the 3 months ending 31 March 2018  Special Points of Interest; Advent Partners 2 Fund completes an investment into premium laser and skin rejuvenation business, Silk Laser Clinics. Adamantem Capital Fund 1 portfolio company, Heritage Lifecare, doubles the number of aged care beds across its facilities, with an additional three aged care…

Continue Reading

VPEG3 Quarterly Report December 2017

22 February 2018 VPEG3 Quarterly Investor Report for the 3 months ending 31 December 2017  Special points of interest; VPEG3 commits $10m to Anchorage Capital Partners Fund III, a $350m turnaround fund, managed by Sydney, Australia based, Anchorage Capital. VPEG3 completes an additional $5m commitment to Adamantem Capital Fund 1 bringing VPEG3’s total commitment to this fund to $10m. Two…

Continue Reading

Advent Partners 2 Invests in Silk Laser Clinics

12 January 2018 Advent today announced that the Advent Partners 2 Fund had completed an investment in premium laser and skin rejuvenation business, Silk Laser Clinics. In 2009, the first Silk Laser Clinic opened in Hyde Park, South Australia, after its four Directors identified a need in the Adelaide market for affordable medical grade laser treatments in a comfortable and…

Continue Reading

Odyssey Private Equity Fund 8 to Acquire Australia’s Favourite Outdoor Leisure Products Business, OZtrail

4 December 2017 LE Whittaker and Sons Pty Ltd (OZtrail) announced today that its shareholders have reached an agreement to enter into a sale transaction with a consortium led by Odyssey Private Equity (Odyssey), Vanessa Garrard and Dr Glen Richards. The terms of the transaction are confidential. As part of the transaction, Odyssey will acquire a controlling interest in the…

Continue Reading